SAP Services – Frequently Asked Questions

CONTACT US – 832-285-3911

INFO@SAPHOUSTON.NET

 What does the SAP process involve?

  • The employee meets with the SAP for an initial evaluation.
  • The SAP will make recommendations based on the initial evaluation.
  • The employee will complete the recommendations, i.e. treatment, education, 12-step meetings, etc.
  • The employee then meets with the SAP for follow up evaluation.
  • The SAP will document that employee has completed all recommendations in letter and may be considered for return to work at the employer’s discretion.

Frequently Asked Questions – From transportation.gov

Overview

The following are some of the questions the Office for Drug and Alcohol Policy and Compliance (ODAPC) has received which did not require an interpretation but rather a general response. As such, the ODAPC staff thought that those subject to Department of Transportation (DOT) testing would benefit from the responses already provided.

These responses do not substitute for the regulations found in 49 CFR Part 40 or any other DOT agency or United States Coast Guard (USCG) specific regulation. If you have a question about the DOT drug and alcohol testing program rules, read the regulatory text.

As an employee or employer, how do I know if I am subject to DOT testing?

Generally, DOT regulations cover safety-sensitive transportation employers and employees. Each DOT agency (e.g. FRA, FMCSA, FTA, FAA, and PHMSA) and the USCG have specific drug and alcohol testing regulations that outline who is subject to their testing regulations.

Also, you may want to try our “Am I Covered?” decision tree.  It will assit you in determining whether or not you are covered.

How does 49 CFR Part 40 differ from the DOT Agency specific regulations?

49 CFR Part 40 (commonly referred to as “Part 40”) states:

  • how drug and alcohol testing is conducted,
  • who is authorized to participate in the drug and alcohol testing program, and
  • what employees must do before they may return-to-duty following a drug and/or alcohol violation.

The DOT Agency and the USCG specific regulations state:

  • the agency’s prohibitions on drug and alcohol use,
  • who is subject to the regulations,
  • what testing is authorized,
  • when testing is authorized, and
  • the consequences of non-compliance.

The DOT Agencies and the USCG incorporate Part 40 into their regulations and enforce compliance of all their respective regulations.

Will I lose my job if I test positive or refuse a test?

The DOT regulations do not address hiring, termination, or other employment actions. These decisions are solely the employer’s, which may be based on company policy and/or any collective bargaining agreements.

What happens to me when I test positive or refuse to test (i.e. adulterate, or substitute my urine specimen, or decline to be tested)?

When you test positive or refuse a test, you are not permitted to perform safety-sensitive duties for any DOT-regulated employer until you have seen a Substance Abuse Professional (SAP) and successfully completed the return-to-duty process, which includes a Federal return-to-duty drug and/or alcohol test.

Working in a safety-sensitive position before successfully completing the return-to-duty process is a violation of the regulations.

Who pays for the DOT drug or alcohol test or SAP recommended treatment/education, the employer or employee?

The Department’s regulations are silent on who is responsible for paying for the testing or SAP recommended treatment/education. Payment may be based an understanding between the employer and employee, including applicants for safety-sensitive positions.

An employer may not, however, refrain from sending a “split specimen” for testing because the employee does not pay for the test in advance.

Is there a list of prohibited drugs for being medically qualified to drive a commercial motor vehicle (CMV)?

Section 391.41(b)(12)(i)&(ii) state:

(12)(i) Does not use any drug or substance identified in 21 CFR 1308.11 Schedule I, an amphetamine, a narcotic, or other habit-forming drug.

(ii) Does not use any non-Schedule I drug or substance that is identified in the other Schedules in 21 part 1308 except when the use is prescribed by a licensed medical practitioner, as defined in § 382.107, who is familiar with the driver’s medical history and has advised the driver that the substance will not adversely affect the driver’s ability to safely operate a commercial motor vehicle.

Medical Examiners are required to give careful consideration to the effects of medications on a driver’s ability to operate a CMV safely before rendering the driver qualified.

Updated: Monday, May 1, 2017